BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 4, 2026
Home » Blogs » BioWorld MedTech Perspectives » MDD's Top 10 deals (so far) of '11

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

MDD's Top 10 deals (so far) of '11

July 14, 2011
By Amanda Pedersen
Dollars seamless background.

Now that the first half of 2011 is already in our rearview mirror, Medical Device Daily has compiled a Top 10 list of the biggest deals so far this year. Admittedly, the list was inspired by the excitement of last week’s dealmaking activity – Medtronic to spend a total of $645 million to buy Salient Surgical Technologies and PEAK Surgical and TPG Capital buying Immucor for $1.97 billion.

So without further ado, here are the Top 10 deals MDD has reported on so far this year, not including any deals that closed this year but were first disclosed last year.

10. TPG Capital (Fort Worth, Texas) is buying Immucor (Norcross, Georgia) for $1.97 billion.

9. Health Care REIT (Toledo, Ohio) bought Genesis Healthcare (Kennett Square, Pennsylvania) for $2.4 billion.

8. Endo Pharmaceuticals (Chadds Ford, Pennsylvania) bought American Medical Systems (Minnetonka, Minnesota) in a $2.9 billion deal.

7. Ventas (Chicago) acquired 118 private-pay senior housing communities of Atria Senior Living Group (Louisville, Kentucky) for $3.1 billion.

6. Emergency Medical Services (Greenwood Village, Colorado) has agreed to be bought out by an affiliate of Clayton, Dubilier & Rice for $3.2 billion.

5. Thermo Fisher Scientific (Waltham, Massachusetts) seeks to acquire Phadia (Uppsala, Sweden) for roughly $3.5 billion.

4. A consortium of private equity investors plan to buy Kinetic Concepts (San Antonio) for $6.3 billion.

3. Danaher (Washington) plans to buy Beckman Coulter (Brea, California) for $6.8 billion.

2.  Ventas says it will acquire Nationwide Health Properties (New Port Beach, California) in a $7.4 billion stock-for-stock deal.

1. Johnson & Johnson (New Brunswick, New Jersey) says it will pay $21.3 billion for Synthes (Solothurn, Switzerland), making it one of the largest med-tech deals in history.

Popular Stories

  • Today's news in brief

    BioWorld
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • University of Southern California reports new MAPT aggregation inhibitors

    BioWorld Science
    The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing